J&J witness testifies in metal-hip lawsuit trial; Boston Scientific seeks zoning changes for new HQ;

 @FierceMedDev: Work advances on early-detection ovarian cancer blood Dx. Story | Follow @FierceMedDev

 @MarkHFierce: J&J faces possible punitive damages in the first verdict regarding faulty vaginal mesh. Thousands of cases to come. Report | Follow @MarkHFierce

 @DamianFierce: The device industry is urging lawmakers to settle on a budget and, of course, repeal the device tax. Article | Follow @DamianFierce

> A witness for Johnson & Johnson ($JNJ) testified that infection rather than a defect forced a patient to have replacement surgery for his ASR metal-on-metal hip. Story

> Boston Scientific ($BSX) is seeking zoning changes to accommodate plans to move its corporate headquarters to Marlborough, MA. Story

> The FDA slapped Woo Young Medical in South Korea with a warning letter, citing the company for quality system violations regarding the manufacturing of its elastomeric infusion pumps. Letter

> The Arizona Heart Foundation is sponsoring U.S clinical trials for a multilayer flow modulator stent made by Cardiatis in Belgium. Story

> With breast cancer cases on the rise, Frost & Sullivan predicts a modest growth in demand for breast-imaging equipment. Item

> Philips is mulling a name change to better reflect the company's diverse business lines, which range from healthcare to lighting and consumer health. Story

> Tandem Diabetes Care won FDA clearance for its t:connect diabetes-management program, a web-based data management system for its t:slim insulin pump. Release

Biotech News

 @FierceBiotech: From FierceVaccines.com: Is it too soon to quit on Nabi's nicotine vaccine? More | Follow @FierceBiotech

 @JohnCFierce: Optimer shares spiking with CEO turned out and the board looking for a buyer. Release | Follow @JohnCFierce

 @RyanMFierce: What Facebook and Google billionaires could do for overlooked biotech brains. Item | Follow @RyanMFierce

> Shionogi wins FDA approval on Osphena for painful sex. Story

> Vertex plots a race through PhIII for 'breakthrough' combo CF therapy. Report

> Jazz strikes up a $120M Concert Pharma collaboration on next-gen Xyrem. More

> Roche follows GSK in move to unlock its data vault on drugs. Article

Pharma News

 @FiercePharma: Allergan settles Botox case in OK. Article | Follow @FiercePharma

 @EricPFierce: AstraZeneca manager accused of getting home makeover at the company's cost. Sunroom, new kitchen, bathroom fixtures. Story | Follow @EricPFierce

> Hospira issues three recalls as it faces crucial FDA inspection. Item

> FDA halts pediatric study of Amgen's Sensipar after death. Story

> India may kill compulsory licensing based on price. More

Drug Delivery News

 @MichaelGFierce: Sanofi's Genzyme hits target with muscular dystrophy RNA drug in mice. Article | Follow @MichaelGFierce

> Ocular Therapeutix submits cataract-surgery sealant for FDA approval. Story

> Synthetic protein tricks immune system for drug delivery, device safety. News

> SHL ups Taiwanese auto injector production by $40M. More

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.